HY-123976-10mg
|
MedChemexpress LLC
|
MPT0G211 [CAS 2151853-97-1]
|
|
Cancer-Kinase/protease
|
|
HY-123976-5mg
|
MedChemexpress LLC
|
MPT0G211 [CAS 2151853-97-1]
|
|
Cancer-Kinase/protease
|
|
HY-123976-1mL
|
MedChemexpress LLC
|
MPT0G211 [CAS 2151853-97-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-147051-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
HY-147051-100mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
HY-147051-25mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
HY-147051-5mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
HY-147051-50mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
HY-114209-10mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-100mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-25mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-5mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-50mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
HY-114209-1mL
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-134813-1mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
HY-134813-10mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
HY-134813-5mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
HY-134813-1mL
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8] (10mM in DMSO)
|
|
|
|
HY-100360-10mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-100mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-25mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-5mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-50mg
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0]
|
|
Cancer-programmed cell death
|
|
HY-100360-1mL
|
MedChemexpress LLC
|
MS049 [CAS 1502816-23-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-133129-1mg
|
MedChemexpress LLC
|
MS1943 [CAS 2225938-17-8]
|
|
Cancer-programmed cell death
|
|